Fragrances in Indonesia to 2014
- Published: July 2010
Introduction
This databook provides key data and information on the Medicated Skin Products Market in Indonesia (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The medicated skin products category was valued at IDR1,608,134.2m ($165.8m) in 2009, representing a CAGR of 6% since 2004.
By the end of 2014, the medicated skin products category will be worth IDR1,978,766.9m ($204m), with an expected CAGR of 4.2% between 2009 and 2014.
The medicated skin products market was led by acne treatments (representing 57.9% of the total value) followed by anti-fungals and anti-bacterials, with a 15.7% and 15.5% market share, respectively. Disinfectants and
READ MORE >
Chapter 1 Executive Summary
Summary category level: medicated skin products
Chapter 2 Definition
Chapter 3 Category Analysis: Medicated Skin Products
Value analysis (Indonesian Rupiah ), 2004-09
Value analysis (Indonesian Rupiah ), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis
Chapter 4 Macroeconomic Profile
Macroeconomic Indicators
Chapter 5 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Medicated skin products, Indonesia, value by segment (IDRm), 2004-14
Figure 2: Medicated skin products, Indonesia, category growth comparison, by value, 2004-14
Figure 3: Medicated skin products, Indonesia, company share by value (%), 2008-09
Figure 4: Medicated skin products, Indonesia, distribution channels by value (%), 2008-09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Medicated skin products category definitions
Table 2: Medicated skin products distribution channels
Table 3: Medicated skin products, Indonesia, value by segment (IDRm), 2004-09
Table 4: Medicated skin products, Indonesia, value forecast by segment (IDRm), 2009-14
Table 5: Medicated skin products, Indonesia, value by segment ($m), 2004-09
Table 6: Medicated skin products, Indonesia, value forecast by segment ($m), 2009-14
Table 7: Medicated skin products, Indonesia, brand share by value (%), 2008-09
Table 8: Medicated skin products, Indonesia, value by brand (IDRm), 2008-09
Table 9: Medicated skin products, Indonesia, company share by value (%), 2008-09
Table 10: Medicated skin products, Indonesia, value by company (IDRm), 2008-09
Table 11: Medicated skin products, Indonesia, distribution channels by value (%), 2008-09
Table 12: Medicated skin products, Indonesia, value by distribution channel (IDRm), 2008-09
Table 13: Indonesia population, by age group, 2004-09 (millions)
Table 14: Indonesia population forecast, by age group, 2009-14 (millions)
Table 15: Indonesia population, by gender, 2004-09 (millions)
Table 16: Indonesia population forecast, by gender, 2009-14 (millions)
Table 17: Indonesia nominal GDP, 2004-09 (IDRbn, nominal prices)
Table 18: Indonesia nominal GDP forecast, 2009-14 (IDRbn, nominal prices)
Table 19: Indonesia real GDP, 2004-09 (IDRbn, 2000 prices)
Table 20: Indonesia real GDP forecast, 2009-14 (IDRbn, 2000 prices)
Table 21: Indonesia real GDP, 2004-09 ($bn, 2000 prices)
Table 22: Indonesia real GDP forecast, 2009-14 ($bn, 2000 prices)
Table 23: Indonesia consumer price index, 2004-09 (2000=100)
Table 24: Indonesia consumer price index, 2009-14 (2000=100)
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Hard Copy | A printed copy of the report will be shipped to you. | |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |